Hougardy Brigitte M T, van der Zee Ate G J, van den Heuvel Fiona A J, Timmer Tineke, de Vries Elisabeth G E, de Jong Steven
Department of Gynecology-Oncology, University Medical Center Groningen, P.O. Box 30001, 9700 RB Groningen, The Netherlands.
Gynecol Oncol. 2005 May;97(2):353-64. doi: 10.1016/j.ygyno.2005.01.036.
Binding of Fas ligand or agonistic anti-Fas antibody to the death receptor Fas can activate a caspase-cascade resulting in apoptosis. In the present study, the functionality of the Fas pathway was studied in human cervical cancer cells with different HPV and p53 status.
HeLa (HPV-18 positive), CaSki, and SiHa (both HPV-16 positive) contain wild-type p53, while C33A (HPV negative) expresses mutant p53. Fas cell surface expression was determined by flow cytometry. Expression of proteins involved in the apoptotic pathway was analyzed by Western blotting and apoptosis was measured by acridine orange staining of nuclear chromatin.
Despite high Fas membrane expression in the HPV-positive cells, CaSki was highly sensitive, HeLa slightly sensitive, and SiHa and C33A were resistant for agonistic anti-Fas antibody. Almost undetectable Fas membrane levels can explain the non-responsiveness of C33A for anti-Fas. Although interferon-gamma (IFNgamma) strongly and cisplatin to a lesser extend enhanced Fas membrane expression in all HPV-positive cells, sensitization to anti-Fas by IFNgamma or cisplatin was only observed in HeLa. Analysis of the Fas apoptotic pathway showed that anti-Fas treatment induced caspase-8 activation and concomitantly Bid cleavage, caspase-9 and caspase-3 activation, PARP cleavage and apoptosis in HeLa and CaSki. IFNgamma plus anti-Fas treatment, in contrast to anti-Fas alone, facilitated caspase-8 activation in HeLa and SiHa, while an increase in Bid cleavage, caspase-9 activation and apoptosis was only observed in HeLa. Apoptotic failure in SiHa (even in the presence of IFNgamma) was probably due to low caspase-8, almost undetectable Bid protein levels and therefore lack of caspase-9 activation.
Sensitivity to anti-Fas depends on Fas, caspase-8, and Bid protein levels in cervical cancer cells. Additionally, IFNgamma and cisplatin can increase sensitivity to anti-Fas in a subset of HPV-positive cervical cancer cell lines by upregulation of Fas and caspase-8 expression without major changes in p53 levels.
Fas配体或激动性抗Fas抗体与死亡受体Fas结合可激活半胱天冬酶级联反应,导致细胞凋亡。在本研究中,我们在具有不同HPV和p53状态的人宫颈癌细胞中研究了Fas通路的功能。
HeLa(HPV-18阳性)、CaSki和SiHa(均为HPV-16阳性)含有野生型p53,而C33A(HPV阴性)表达突变型p53。通过流式细胞术测定Fas细胞表面表达。通过蛋白质印迹分析凋亡途径中相关蛋白的表达,并通过吖啶橙染色核染色质测定细胞凋亡。
尽管HPV阳性细胞中Fas膜表达较高,但CaSki对激动性抗Fas抗体高度敏感,HeLa稍敏感,而SiHa和C33A对其耐药。几乎检测不到的Fas膜水平可以解释C33A对抗Fas无反应的原因。虽然干扰素-γ(IFNγ)强烈且顺铂在较小程度上增强了所有HPV阳性细胞中Fas膜的表达,但仅在HeLa中观察到IFNγ或顺铂使细胞对抗Fas敏感。对Fas凋亡途径的分析表明,抗Fas处理可诱导HeLa和CaSki中半胱天冬酶-8激活,并伴随Bid裂解、半胱天冬酶-9和半胱天冬酶-3激活、PARP裂解和细胞凋亡。与单独使用抗Fas相比,IFNγ加抗Fas处理促进了HeLa和SiHa中半胱天冬酶-8的激活,而仅在HeLa中观察到Bid裂解增加、半胱天冬酶-9激活和细胞凋亡增加。SiHa中凋亡失败(即使在存在IFNγ的情况下)可能是由于半胱天冬酶-8水平低、Bid蛋白水平几乎检测不到,因此缺乏半胱天冬酶-9激活。
宫颈癌细胞对抗Fas的敏感性取决于Fas、半胱天冬酶-8和Bid蛋白水平。此外,IFNγ和顺铂可通过上调Fas和半胱天冬酶-8表达而不改变p53水平,增加一部分HPV阳性宫颈癌细胞系对抗Fas的敏感性。